Quest Diagnostics
DGX
#1142
Rank
$21.01 B
Marketcap
$189.81
Share price
1.29%
Change (1 day)
8.40%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2026 (TTM): $1.37 Billion USD

According to Quest Diagnostics 's latest financial reports the company's current earnings are $11.27 Billion USD. In 2025 the company made an earning of $1.31 Billion USD, an increase over its 2024 earnings that were of $1.17 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $1.37 B4.4%
2025 $1.31 B12.17%
2024 $1.17 B3.98%
2023 $1.13 B-8.5%
2022 $1.23 B-52.48%
2021 $2.59 B37.95%
2020 $1.88 B75.09%
2019 $1.07 B16.2%
2018 $0.92 B-10.1%
2017 $1.03 B-5.16%
2016 $1.08 B-1.54%
2015 $1.10 B31%
2014 $0.84 B-37.52%
2013 $1.34 B26.93%
2012 $1.06 B24.01%
2011 $0.85 B-27.7%
2010 $1.18 B-3.55%
2009 $1.22 B19.59%
2008 $1.02 B12.54%
2007 $0.91 B-11.7%
2006 $1.03 B13.49%
2005 $0.91 B9.02%
2004 $0.83 B13.19%
2003 $0.73 B36.03%
2002 $0.54 B63.07%
2001 $0.33 B65.49%
2000 $0.20 B1297.84%
1999 $14.37 M-73.37%
1998 $54 M-384.21%
1997 -$19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
$1.37 B-0.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
$41.68 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-$1.92 Million-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-$99.46 Million-107.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$0.52 B-61.95%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-$7.85 Million-100.57%๐Ÿ‡บ๐Ÿ‡ธ USA